Identification and utilization of genetic mutations in the treatment of ovarian cancer

被引：0
|
作者：
Johnson, A. [1 ]
Hawkins, G. M. [1 ]
Kouri, A. [1 ]
Clark, L. H. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.464
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
576
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [41] Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis
    Ye, Q.
    Lei, L.
    Aili, A. X.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (03) : 283 - 289
  • [42] Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization
    Douglas E. Levy
    Judy E. Garber
    Alexandra E. Shields
    [J]. Journal of General Internal Medicine, 2009, 24 : 822 - 828
  • [43] Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients
    Nagasawa, Saya
    Ikeda, Kazuhiro
    Horie-Inoue, Kuniko
    Sato, Sho
    Takeda, Satoru
    Hasegawa, Kosei
    Inoue, Satoshi
    [J]. ENDOCRINE JOURNAL, 2020, 67 (02) : 219 - 229
  • [44] Identification and Treatment of Recurrent Ovarian Cancer in a Large Administrative Claims Database
    Chia, Victoria M.
    Lethen, Jan
    Cyprien, Lori
    Kelsh, Michael
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 394 - 395
  • [45] Ovarian and breast cancer prevention: is it time for population-based genetic testing for BRCA mutations?
    Campbell, I.
    Trainer, A.
    Young, M. A.
    Devereux, L.
    Paul, J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 80 - 80
  • [46] UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR MONOGENIC GENE MUTATIONS ASSOCIATED WITH INCREASED CANCER RISK.
    Walker, Karrie A. B.
    Namath, Amalia
    Jahandideh, Samad
    Devine, Kate
    Hill, Micah J.
    DeCherney, Alan H.
    Bromer, Jason
    O'Brien, Jeanne E.
    [J]. FERTILITY AND STERILITY, 2021, 116 (03) : E56 - E57
  • [47] Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low Utilization
    Levy, Douglas E.
    Garber, Judy E.
    Shields, Alexandra E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (07) : 822 - 828
  • [48] Assessing the Relevance of Molecular Genetic Testing for Mutations in BRCA Genes of Patients with Ovarian and Breast Cancer
    V. A. Lemeshko
    T. S. Teptsova
    S. S. Ratushnyak
    N. Z. Musina
    [J]. Russian Journal of Genetics, 2020, 56 : 1391 - 1405
  • [49] Bladder Cancer and Genetic Mutations
    Zhang, Xiaoying
    Zhang, Yangde
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 73 (01) : 65 - 69
  • [50] Bladder Cancer and Genetic Mutations
    Xiaoying Zhang
    Yangde Zhang
    [J]. Cell Biochemistry and Biophysics, 2015, 73 : 65 - 69
12345